Article info

Download PDFPDF

The feasibility of finger prick autologous blood (FAB) as a novel treatment for severe dry eye disease (DED): protocol for a randomised controlled trial

Authors

  1. Correspondence to Dr Arit Udoh; arctu{at}anglia.ac.uk
View Full Text

Citation

Balal S, Udoh A, Pappas Y, et al
The feasibility of finger prick autologous blood (FAB) as a novel treatment for severe dry eye disease (DED): protocol for a randomised controlled trial

Publication history

  • Received September 18, 2018
  • Revised September 25, 2018
  • Accepted September 26, 2018
  • First published October 31, 2018.
Online issue publication 
October 31, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.